Navigation Links
Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 24th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Tuesday, November 27 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Third Quarter 2012 Results
2. Neurocrine Biosciences Reports Second Quarter 2012 Results
3. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
4. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
5. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
6. Amarantus BioSciences Wins MANF Patent Challenge in Europe
7. Amarantus BioSciences Issues CEO Letter to Shareholders
8. Amarantus BioSciences Secures $1.1 Million in Financing
9. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
10. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
11. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... SAN FRANCISCO, July 20 Burrill & Company, a San ... Private Equity, Merchant Banking and Media, is pleased to announce that ... Director, for both Burrill & Company and Burrill Latin America. ... of Rio Bravo Venture Partners, an asset management firm created from ...
... BOZEN, Italy, July 20 Health ... with Charite-Universitatsmedizin,Berlin. Charite will install an i.v.STATION robot at ... The primary challenges in today,s ... time, waste, regulatory issues,lack of audit trails, motion injuries, ...
... , BASKING RIDGE, N.J., July ... the development of antithrombotic therapeutic aptamers with active control agents, ... Three new members (Dr. John Eikelboom of Canada, Dr. ... join the original members bringing the current size of the ...
Cached Biology Technology:Joao Paulo Baptista Joins Burrill & Company 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 3Regado Biosciences Expands Medical Advisory Board 2Regado Biosciences Expands Medical Advisory Board 3Regado Biosciences Expands Medical Advisory Board 4
(Date:4/24/2014)... 2014GEN Publishing recently introduced Clinical OMICs ... the application of OMICs technologies in clinical settings. ... beginning to transform medical care just as they ... decade-and-a-half. , "GEN,s editors and reporters have written ... transcriptomics, etc. etc. for years," said John Sterling, ...
(Date:4/24/2014)... invented a simple and cheap way of making a ... a high-resolution microscope. , Costing less than a cent, ... in developing countries and remote areas. , The lens ... The Australian National University (ANU) Research School of Engineering, ... Institute of Medical Research to find ways to transform ...
(Date:4/24/2014)... North Carolina State University and the University of North ... device that could help identify arterial plaque that is ... attack or stroke. , At issue is the plaque ... types of plaque are deemed "vulnerable," meaning that they ... and cause heart attack or stroke. , "Existing state-of-the-art ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2
... Assistant Professor, Department of Microbiology & Immunology, University of ... with one of two 2012 Merck Irving S. Sigal ... scientists to recognize and award excellence in basic research ... memory of Irving S. Sigal, an instrumental figure in ...
... Kaye Wachsmuth, Ph.D., International Public Health Consultant, DeLand, ... Public Health Award. This award, established in honor ... who has exhibited exemplary leadership and service in ... award "for almost forty years of implementing state-of-the-art ...
... Talk about throwing yourself into a relationship too soon. A ... gets a whiff of female sex attractant, he,s quicker to start ... prematurely when he,s still too cool for powerful flight. So his ... race. The study illustrates the tradeoff between being quick to ...
Cached Biology News:The American Society for Microbiology honors Susan Sharp 2The American Society for Microbiology honors I. Kaye Wachsmuth 2The American Society for Microbiology honors I. Kaye Wachsmuth 3Virgin male moths think they're hot when they're not 2Virgin male moths think they're hot when they're not 3Virgin male moths think they're hot when they're not 4Virgin male moths think they're hot when they're not 5
12 breakable polypropylene strips of 8 wells each held in a rigid frame. Ideal for antibody assays....
... in vitro diagnostic assays, all EIA/RIA plates ... uniform binding, high optical clarity and low ... part of the Certified Surface Chemistry Programme, ... within QA release specifications. Linkage: This CLS ...
... Stabilizer is an aqueous solution that contains ... stabilizing chemicals in a saline solution, pH ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ... a diluent and stabilizer for biologically active ...
AC input: 230 V...
Biology Products: